semaglutide vs dulaglutide 87 - Efficacy and Safety of 0.5 mg 1.5 mg Once Weekly in Type 2 Diabetes: Posthoc Analysis of SUSTAIN 7 Simulation scenarios for switching from

At six months, people taking GLP-1 drugs were: 26 percent more likely to develop nonscarring hair loss, an umbrella term for types of hair loss where the follicles are still intact and regrowth is possible 62 percent more likely to develop pattern hair thinning, such as thinning at the crown or widening of the part in women, or a receding hairline in men

The drug showed an acceptable safety profile

Check serum IGF-1 at baseline and at 4 weeks before titrating upward

For enhanced results, regularly exfoliate the eye area using THE PEELUMINATOR

For a broader look at how GLP-1 treatment changes hunger and digestion, our article on how GLP-1 medications help with weight loss is worth a look